Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

Wednesday’s trading has closed, but MNTA is being traded in the after-hours session. After-Hours quote »
21.96
Delayed Data
As of 3:59pm ET
 -0.47 / -2.10%
Today’s Change
9.38
Today|||52-Week Range
25.56
+82.39%
Year-to-Date

Today’s Trading

Previous close22.43
Today’s open22.45
Day’s range21.67 - 22.47
Volume374,586
Average volume (3 months)988,075
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+10.33%
Earnings growth (this year)+61.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+47.33%
P/E ratioNM
Price/Sales11.91
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
RLYPRelypsa Inc-0.58-1.67%
AXONAxovant Sciences Ltd-1.09-6.83%
MCRBSeres Therapeutics I...+1.20+3.29%
ESPREsperion Therapeutic...-6.53-9.46%
Data as of 4:01pm ET, 07/29/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$52.3M
Annual profit (last year)-$98.6M
Net profit margin-188.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer &
Senior Vice President
Richard P. Shea
Corporate headquarters
Cambridge, Massachusetts

Forecasts